Barclays keeps a USD 96.00 target on Addus HomeCare stock

Published on 10/25/2026 at 03:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 8.00 percent to USD 377.41 million in 2026. Addus HomeCare stock last stood at USD 121.81 on Nasdaq October 23, 2026.

Analyst view meets earnings calendar

Barclays maintained a USD 96.00 target and Sell rating on October 7, 2026.
Second-quarter 2026 revenue rose 8.00 percent to USD 377.41 million.
Addus HomeCare will report third-quarter 2026 results on November 3, 2026.

ADUS, US0067391062, Illustration mit AI erstellt.

Addus HomeCare (ISIN US0067391062) faced a USD 96.00 price target and Sell rating from Barclays on October 7, 2026, according to Markets Insider. The analyst view contrasts with a broader Moderate Buy consensus and keeps the November reporting date central to the stock story.

Three dates shape the setup

On July 8, 2026, Barclays raised its target from USD 92.00 to USD 96.00 and assigned an underweight rating, as MarketBeat reported. On August 3, 2026, Addus reported second-quarter earnings per share of USD 1.73 against a USD 1.70 consensus estimate, while revenue reached USD 377.41 million, up 8.00 percent year over year, according to MarketBeat. On October 13, 2026, Addus announced the reporting schedule for the third quarter ended September 30, as Business Wire reported.

What does the target mean?

The USD 96.00 target sits below the latest Nasdaq price, while the operating figures provide a more constructive counterpoint. MarketBeat said eleven analysts covered Addus with five Buy ratings, one Strong Buy, four Holds and one Sell, producing an average target of USD 129.33 on October 13, 2026. The same report said institutional investors owned 95.35 percent of outstanding shares.

The second-quarter comparison also gives investors a measurable test for the next report. Addus revenue increased 8.00 percent year over year to USD 377.41 million, while earnings per share exceeded consensus by USD 0.03, according to MarketBeat. That combination leaves the next reported revenue and earnings figures as the clearest check on the competing analyst views.

When are the next results?

Addus is scheduled to release third-quarter 2026 results on November 3, 2026, after the Nasdaq market close, followed by a conference call on November 4, 2026, at 9:00 a.m. ET, according to Business Wire. The company said it served approximately 62,500 patients and consumers through 264 locations across 24 states in the October 13 announcement.

Stock price and valuation context

Addus HomeCare last stood at USD 121.81 on Nasdaq on October 23, 2026, at 4:00 p.m. EDT. Its market capitalization was USD 2.3 billion, and its 52-week range was USD 87.95 to USD 124.44 as of October 23, 2026. The further course of trading is shown by the continuously updated real-time quote of Addus HomeCare stock.